NCT02717234已完成不适用
Appearance of Plasma Amino Acids Following Consumption of an Oral Nutrition Supplement
Société des Produits Nestlé (SPN)0 个研究点目标入组 12 人开始时间: 2016年2月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 12
- 主要终点
- Change in plasma arginine levels in µmol/L
研究概览
简要总结
To assess the effect of consumption of an oral nutrition supplement on Arginine, a blood marker of nutritional intake
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Other
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy subject (absence of metabolic disorder, heart disease, endocrine disease, cancer)
- •Discontinued use of omega 3 fatty acid supplements - 10 days prior to testing
- •Willing to provide signed informed consent
排除标准
- •Patients with potential for non-compliance
- •Patients with allergy to ingredients in test products (i.e. milk protein, fish oil)
- •Subject who in the Investigator's assessment cannot be expected to comply with study protocol
- •Currently participating in another conflicting clinical trial.
结局指标
主要结局
Change in plasma arginine levels in µmol/L
时间窗: Pre-consumption, 30, 60, 120, 180, 240 minutes
次要结局
- Change in plasma phospholipid Eicosapentaenoic acid (EPA) in µg/ml(Pre-consumption, 30, 60, 120, 180, 240 minutes)
- Change in plasma-free phospholipid Eicosapentaenoic acid (EPA) in µg/ml(Pre-consumption, 30, 60, 120, 180, 240 minutes)
研究者
相似试验
终止
不适用
Oral Nutritional Supplement in Reducing Surgical Site InfectionsClaudicationPeripheral Vascular DiseaseNCT02475525University of Limerick6
已完成
不适用
Effect of the Amino Acid L-arginine on Perioperative Cardio-vascular Risk in Non-selected PatientsCardiovascular ComplicationNCT01413815Universitätsklinikum Hamburg-Eppendorf269
已完成
不适用
Effect of Arginine Supplementation in the Metabolic SyndromeOverweightHypertriglyceridemic WaistNCT02354794Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement36
已完成
不适用
L-Citrulline in Peripheral Artery DiseasePeripheral Arterial DiseaseNCT02521220Maastricht University49
Unknown
不适用
The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for Treatment of Pressure UlcersPressure Ulcers Stage IIIPressure Ulcer, Stage IVNCT03038490Our Lady of Maryknoll Hospital90
